Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer

K. Tanaka, W. Shuo, M. Takeshita, M. Izumi, K. Takayama, Y. Nakanishi (Fukuoka, Japan)

Source: Annual Congress 2010 - Pathology of lung cancer
Session: Pathology of lung cancer
Session type: Thematic Poster Session
Number: 3268
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

(Background) Nicotine, which is a major component of tobacco smoke, has been known as the principal psycoactive component to induce addiction by exerting its effects on the nicotinic acetylcholcholine receptors (nAchR) composed of alpha and beta subunits in the central nervous system. This addiction is thought to lead to the high incidence of the lung cancer through exposure to many carcinogens in the lung. Besides this, recent several reports suggested that nicotine might play another role in lung cancer by promoting in vivo the growth of cancer cells via nAcR signaling. nAchR exists in non-neural organs including lung. However, the precise mechanism how nicotine induces lung cancer remains to be elucidated.
(Methods and results) To know expression profiles, we analyzed nAchR expression by immunohistochemistry in 24 Asian (Japanese) patients‘ specimen diagnosed as lung cancer (18 adenocarcinoma, 4 Squamous cell carcinoma, 1 large cell carcinoma and 1 small cell carcinoma) by Department of Pathology in Kyushu University. Interestingly, we found out that alpha 1 subunit was significantly expressed high in comparison to alpha 7 and other subunits.
(Conclusions) Differnt from previous reports that alpha 7 might be important, we got an interesting result that alpha 1 would be also related to lung cancer. Each subunit in nAchR may have an essential and unique function in oncogenesis.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Tanaka, W. Shuo, M. Takeshita, M. Izumi, K. Takayama, Y. Nakanishi (Fukuoka, Japan). Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3268

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Histamine receptors in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

Hypoxia-mediated alterations in adenosine receptor expression in rat lung
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Increased relaxation of immature airways to beta-2 agonists is related to the attenuated expression of postjunctional smooth muscle muscarinic M2 receptors
Source: Annual Congress 2004 - Understanding the complexity of how airways are regulated
Year: 2004


The antitussive effects of alpha7 (a7) nicotinic receptor agonists
Source: International Congress 2017 – Novel studies on bronchodilators and cough
Year: 2017



Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond
Source: Eur Respir J, 56 (2) 2001610; 10.1183/13993003.01610-2020
Year: 2020



Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019



Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 121s
Year: 2005

Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Source: Eur Respir J 2008; 32: 426-436
Year: 2008



Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects
Source: Eur Respir J 2008; 31: 311-319
Year: 2008



In vivo potent and long-lasting bronchodilator activity of muscarinic M3 receptor antagonist CHF5407
Source: Eur Respir J 2007; 30: Suppl. 51, 26s
Year: 2007

Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019

Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists
Source: Eur Respir Monogr 2020; 88: 238-250
Year: 2020


Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Source: Eur Respir J 2008; 32: 555-562
Year: 2008



Expression of endothelin receptor subtypes in different pulmonary tumours
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Pharmacological activities of R-113281, a triple NK1 /NK2 /NK3 neurokinin receptor antagonist
Source: Eur Respir J 2001; 18: Suppl. 33, 264s
Year: 2001